Medicare Enrolled
Dr. Magdy Elsakr, M.D.
Optician · Modesto, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Elsakr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elsakr?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Elsakr
Dr. Magdy Elsakr is an optician specialist in Modesto, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Elsakr performed 1,295 Medicare services across 1,192 unique beneficiaries.
Between the years covered by Open Payments, Dr. Elsakr received a total of $26,159 from 46 pharmaceutical and/or device companies across 1054 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Elsakr is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 48% volume in CA
$26,159 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,295
Medicare services
Top 48% in CA for optician
1,192
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $91 | $188 |
| New patient office visit, complex (60-74 min) | 191 | $152 | $362 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
183 | $56 | $858 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
155 | $70 | $1,143 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
134 | $4 | $100 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
115 | $204 | $1,275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $108 | $287 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
37 | $103 | $690 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses an endoscope and a mechanical snare to remove polyps or growths from the esophagus, stomach, or upper small bowel. |
33 | $129 | $813 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
26 | $178 | $756 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
22 | $123 | $957 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $137 | $254 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
15 | $176 | $765 |
| Endoscopic control of upper GI bleeding A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine. |
12 | $146 | $954 |
| Endoscopic destruction of esophagus, stomach, or bowel growth Removal of a polyp or growth in the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The procedure is performed through the mouth to access and destroy the abnormal tissue. |
12 | $174 | $510 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$26,159
Total received (2018-2024)
Avg $3,737/year across 7 years
Top 7% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,054
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,678 (79.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,451 (20.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,508
2023
$3,815
2022
$3,705
2021
$2,467
2020
$2,001
2019
$7,436
2018
$3,227
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$875
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$318
Lilly USA, LLC
$308
Janssen Biotech, Inc.
$297
Gilead Sciences, Inc.
$254
PFIZER INC.
$197
Celltrion USA Inc.
$196
GENZYME CORPORATION
$168
Ardelyx, Inc.
$164
Phathom Pharmaceuticals, Inc.
$142
Madrigal Pharmaceuticals
$121
IRONWOOD PHARMACEUTICALS, INC
$91
Boston Scientific Corporation
$70
Celgene Corporation
$68
Takeda Pharmaceuticals U.S.A., Inc.
$67
Braintree Laboratories, Inc.
$38
Merck Sharp & Dohme LLC
$35
Biocon Biologics Inc
$35
Intercept Pharmaceuticals, Inc.
$24
Organon Llc
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$6,161
ABBVIE INC.
$3,088
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,331
Janssen Biotech, Inc.
$1,552
Takeda Pharmaceuticals U.S.A., Inc.
$1,405
AbbVie Inc.
$1,287
Gilead Sciences, Inc.
$1,249
AbbVie, Inc.
$1,083
Celgene Corporation
$1,060
GENZYME CORPORATION
$443
Allergan Inc.
$430
Braintree Laboratories, Inc.
$422
Synergy Pharmaceuticals Inc
$409
Intercept Pharmaceuticals, Inc.
$382
Ferring Pharmaceuticals Inc.
$376
Ironwood Pharmaceuticals, Inc
$371
E.R. Squibb & Sons, L.L.C.
$351
Ardelyx, Inc.
$339
RedHill Biopharma Inc.
$315
Lilly USA, LLC
$308
Celltrion USA Inc.
$226
INTERCEPT PHARMACEUTICALS, INC.
$223
Shionogi Inc
$220
Janssen Scientific Affairs, LLC
$219
IRONWOOD PHARMACEUTICALS, INC
$208
Merck Sharp & Dohme Corporation
$186
AstraZeneca Pharmaceuticals LP
$160
Boston Scientific Corporation
$157
Phathom Pharmaceuticals, Inc.
$142
Regeneron Healthcare Solutions, Inc.
$125
Dova Pharmaceuticals
$121
Madrigal Pharmaceuticals
$121
Prometheus Laboratories Inc.
$113
Merck Sharp & Dohme LLC
$100
Daiichi Sankyo Inc.
$59
Advanced Accelerator Applications
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Shire North American Group Inc
$51
QOL Medical, LLC
$49
Nestle HealthCare Nutrition Inc.
$48
Concordia Pharmaceuticals Inc.
$41
Biocon Biologics Inc
$35
Ethicon US, LLC
$30
Organon Llc
$22
Organon LLC
$17
COVIDIEN LP
$11
Top 3 companies account for 44.3% of all-time payments
Associated products mentioned in payments ›
APRISO · Amitiza · BARRX · CIMZIA · CLENPIQ · CREON · CYLTEZO · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · Doptelet · ENTYVIO · EOHILIA · EXALT Model D · Entyvio · Epclusa · GATTEX · HADLIMA · HUMIRA · Hulio · Humira · IBSRELA · INJECTAFER · LINZESS · LUTATHERA · Linzess · Livdelzi · MAVYRET · MOTEGRITY · MOVANTIK · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · ORENCIA · REBYOTA · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Spyglass · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · Vemlidy · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · YUFLYMA · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for optician in CA.
Geographic Context
Opticians within 10 mi
173
Per 100K population
31.3
County median income
$79,661
Nearest hospital
MEMORIAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Elsakr is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Elsakr experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Elsakr performed 268 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Elsakr receive payments from pharmaceutical companies?
Yes. Dr. Elsakr received a total of $26,159 from 46 companies across 1,054 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Elsakr's costs compare to other opticians in Modesto?
Dr. Elsakr's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Elsakr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Modesto
Browse opticians in Modesto ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology